We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Etanercept is safely used for treating psoriatic arthritis in a patient complicated with type 1 hereditary angioedema.
- Authors
Umegaki, Noriko; Kira, Masahiro; Horiuchi, Takahiko; Itoi, Saori; Tani, Mamori; Yokomi, Akinori; Tanemura, Atsushi; Miyahara, Hisaaki; Hatanaka, Michiyo; Kitamura, Hajime; Kitano, Etsuko; Katayama, Ichiro
- Abstract
Hereditary angioedema (HAE) is a life-threatening disorder caused by deficiency or dysfunction of the C1 inhibitor protein. Patients with HAE are restricted in various medical treatments, which can induce an HAE attack. We herein report the first case of psoriatic arthritis (PSA) with type 1 HAE successfully treated with 25 mg of etanercept without HAE attack. Etanercept may represent a useful choice for treating patients with HAE accompanied by intractable PSA and rheumatoid arthritis (RA).
- Subjects
ETANERCEPT; MEDICATION safety; PSORIATIC arthritis; ANGIONEUROTIC edema; GENETIC disorders; RHEUMATOID arthritis; PROTEIN deficiency; THERAPEUTICS
- Publication
Modern Rheumatology, 2012, Vol 22, Issue 6, p928
- ISSN
1439-7595
- Publication type
Article
- DOI
10.3109/s10165-012-0604-2